The Analyst Verdict: Addus HomeCare In The Eyes Of 9 Experts
Portfolio Pulse from Benzinga Insights
Addus HomeCare (NASDAQ:ADUS) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. Analysts have set a 12-month average price target of $141.56, reflecting a 4.56% increase from the previous target. The company's financial performance shows strong revenue growth and profitability, with a notable net margin and return on equity.
October 11, 2024 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Addus HomeCare has received mostly somewhat bullish ratings from analysts, with a 12-month price target averaging $141.56, indicating a positive outlook. The company's financials show strong revenue growth and profitability, which may support the stock price.
The majority of analysts have a somewhat bullish outlook on Addus HomeCare, with a 12-month price target that is higher than the previous average. The company's strong financial performance, including revenue growth and profitability, supports a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100